SEMPRA financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SEMPRA files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	10,183	9,640	10,102	10,829	11,370	12,857	14,439	16,720	13,185	13,702
Interest expense	553	622	886	1,077	1,081	1,198	1,054	1,309	1,049	1,532
Interest income	26	24	85	87	96	69	75	89	61	103
Other non-operating income	138	233	72	77	-48	58	24	131	136	169
Pre-tax income	1,830	1,282	478	1,764	1,783	833	2,009	3,260	2,713	1,789
Income tax	389	938	-49	315	249	99	556	490	219	701
Net income to minority interests	148	94	76	164	172	145	146	543	638
Net income	1,370	256	924	2,055	3,764	1,318	2,139	3,075	2,862	1,837
EPS, basic	2.75	0.51	1.73	3.71	6.48	2.01	3.32	4.81	4.44	2.75
EPS, diluted	2.74	0.51	1.71	3.65	6.46	2.01	3.31	4.79	4.42	2.75
Shares, basic (weighted)	499	502	535	554	581	624	630	630	634	653
Shares, diluted (weighted)	501	503	538	563	583	626	633	633	638	654
Dividend per share	1.51	1.65	1.79	1.94	2.10	2.20	2.29	2.38	2.48	2.58

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	349	288	102	108	960	559	370	236	1,565	29
Receivables	1,390	1,307	1,215	1,261	1,578	2,071	2,635	2,151	1,983	1,767
Inventory	258	307	258	277	308	389	403	482	559	561
Other current assets	142	202	249	163	149	30	49	56	380	262
Total current assets	3,110	3,341	3,645	3,339	4,511	4,375	5,912	5,470	5,285	34,837
Property, plant and equipment	32,931	36,503	34,439	36,452	40,003	43,894	47,782	54,960	61,437	49,011
Lease right-of-use assets				591	543	594	655	723	1,177	1,262
Goodwill	2,364	2,397	1,602	1,602	1,602	1,602	1,602	1,602	1,602	0
Intangible assets	548	596	224	213	202	370	344	318	292	0
Other non-current assets	520	792	962	732	753	1,244	1,382	1,603	1,749	1,300
Total assets	47,786	50,454	60,638	65,665	66,623	72,045	78,574	87,181	96,155	110,878
Accounts payable	1,346	1,350	1,160	1,234	1,359	1,671	1,994	2,211	2,238	1,461
Accrued liabilities	409	439	440	476	446	479	484	526	558	521
Short-term debt	913	1,427	1,644	1,526	1,540	106	1,019	975	2,274	1,876
Total current liabilities	5,927	6,635	7,523	9,150	6,839	10,035	9,899	10,090	9,676	21,894
Long-term debt	14,429	16,445	20,903	20,785	21,781	21,068	24,548	27,759	31,558	28,979
Lease liabilities				445	407	470	528	599	1,019	1,176
Other non-current liabilities							301	307	352	0
Total liabilities	32,545	35,314	41,390	43,860	41,689	44,626	49,318	53,527	58,367	72,085
Total debt	15,342	17,872	22,547	22,311	23,321	21,174	25,567	28,734	33,832	30,855
Retained earnings	10,717	10,147	10,104	11,130	13,673	13,548	14,201	15,732	16,979	17,092
Other comprehensive income	-748	-626	-764	-939	-500	-318	-135	-150	-166	-197
Shareholders' equity	12,951	12,670	17,138	19,929	23,373	25,981	27,115	28,675	31,222	31,594
Minority interests	2,270	2,450
Total equity	15,241	15,140	19,248	21,805	24,934	27,419	29,256	33,654	37,788	38,793
Total liabilities and equity	47,786	50,454	60,638	65,665	66,623	72,045	78,574	87,181	96,155	110,878
Shares outstanding	499	501	546	582	1,151	634	629	631	651	653

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	1,519	351	1,126	2,362	4,105	1,463	2,285	3,618	3,500	2,072
Depreciation and amortization	1,312	1,436	1,491	1,569	1,666	1,855	2,019	2,227	2,437	2,563
Stock-based compensation	52	82	83	75	71	63	71	80	86	64
Deferred income tax	222	889	-238	192	159	-77	392	187	-28	568
Change in inventory	-20	-42	32	-22	-35	-87	-17	-80	-74	-64
Change in payables	122	84	96	17	74	263	430	-270	-131	-7
Cash from operations	2,311	3,625	3,516	3,088	2,591	3,842	1,142	6,218	4,907	4,565
Capital expenditures	-4,214	-3,705	-3,544	-3,708	-4,676	-5,015	-5,357	-8,397	-8,215	-10,612
Acquisitions	1,342	-147	-9,568	0	0
Purchases of investments	-1,582	-269	-10,168	-1,797
Sales and maturities of investments	1,134	1,314	890	914	1,439	961	639	592	874	974
Cash from investing	-4,835	-4,885	-12,470	-4,593	553	-5,508	-5,039	-8,716	-9,118	-12,537
Debt issued	2,951	4,260	8,927	4,296	6,051	3,773	9,984	7,669	8,674	11,282
Debt repaid	-2,057	-2,587	-3,342	-3,667	-5,864	-5,489	-4,510
Stock issued	51	47	2,272	1,830	11	5	4	145	1,219	32
Share buybacks	-56	-15	-21	-26	-566	-339	-478	-32	-43	-58
Dividends paid	-686	-755	-877	-993	-1,174	-1,331	-1,430	-1,483	-1,499	-1,603
Cash from financing	2,502	1,192	8,850	1,475	-2,373	1,260	3,779	2,419	5,424	9,930
Exchange rate effect	-3	-2	-2	0	0	2	-1	6	-13
Net change in cash	-25	-61	-118	-29	768	-404	-119	-73	1,200	1,963
Free cash flow	-1,903	-80	-28	-620	-2,085	-1,173	-4,215	-2,179	-3,308	-6,047
Interest paid	532	599	773	1,051	1,046	1,163	1,014	1,172	1,205	1,449
Income taxes paid	160	122	174	360	1,385	230	284	197	289	376

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to March 31, 2026; growth uses fiscal years. Valuation uses the share price of $77.93 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Pre-tax margin	14.7%	Pre-tax income / revenue.
Net margin	14.4%	Net income / revenue.
FCF margin	-43.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	36.1%	Cash from operations / revenue.
Effective tax rate	35.6%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	6.1%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	1.7%	Net income / average total assets.
Stock-based pay / revenue	0.7%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	79.2%	Capital expenditures / revenue.
D&A / revenue	18.8%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.9%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-1.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	3.8%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-35.8%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-4.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-13.4%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-37.8%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-6.0%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-15.7%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-7.0%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	58.7%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	12.0%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Dividend per share growth, 1y	4.0%	Dividend per share vs the same period a year earlier. Only from a positive base.
Dividend per share CAGR, 3y	4.1%	Compound annual growth of dividend per share over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Dividend per share CAGR, 5y	4.3%	Compound annual growth of dividend per share over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	1.2%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	5.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	6.2%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	15.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	12.2%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	10.7%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	2.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	1.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	2.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.69x	Current assets / current liabilities.
Quick ratio	0.11x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.04x	(Cash + short-term investments) / current liabilities.
Debt / equity	1.02x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	28.8%	Total debt / total assets.
Liabilities / assets	65.2%	Total liabilities / total assets.
Net debt	$31.93B	Total debt - cash - short-term investments. Negative means more cash than debt.
Working capital	$14.76B	Current assets - current liabilities.
Tangible book value	$32.24B	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.12x	Revenue / average total assets.
Fixed asset turnover	0.28x	Revenue / average property, plant and equipment.
Receivables turnover	8.45x	Revenue / average receivables.
Days sales outstanding	43 days	365 x average receivables / revenue.
FCF conversion	-298.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	219.5%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$2.99	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$20.68	Revenue / diluted weighted shares.
FCF per share	-$8.92	Free cash flow / diluted weighted shares.
Operating cash flow per share	$7.46	Cash from operations / diluted weighted shares.
Book value per share	$49.34	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$49.34	Tangible book value / shares outstanding.
Cash per share	$1.22	(Cash + short-term investments) / shares outstanding.
Payout ratio	83.4%	Dividends paid / net income, when net income is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$50.96B	Share price x shares outstanding.
Enterprise value	$82.89B	Market cap + total debt - cash - short-term investments.
P/E	26.0x	Market cap / net income. Only when net income is positive.
P/S	3.76x	Market cap / revenue.
P/B	1.58x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	1.58x	Market cap / tangible book value, when positive.
P/OCF	10.4x	Market cap / cash from operations, when positive.
EV/Sales	6.12x	Enterprise value / revenue.
FCF yield	-11.5%	Free cash flow / market cap.
Earnings yield	3.8%	Net income / market cap (the inverse of P/E).
Dividend yield	3.2%	Dividends paid over the period / market cap.
Shareholder yield	3.2%	(Dividends paid + share buybacks) / market cap.

What was SEMPRA's revenue in fiscal 2025?

SEMPRA reported revenue of $13.70B for fiscal 2025, 3.9% higher than the year before.

Was SEMPRA profitable in fiscal 2025?

Yes. Net income was $1.84B, a net margin of 13.4%.

How much free cash flow did SEMPRA generate in fiscal 2025?

Cash from operations of $4.57B minus capital expenditures of $10.61B left free cash flow of -$6.05B.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to SEMPRA